chr1-248473649-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005495.1(OR2T3):c.299C>T(p.Ser100Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,611,682 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005495.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2T3 | NM_001005495.1 | c.299C>T | p.Ser100Leu | missense_variant | 1/1 | ENST00000359594.3 | NP_001005495.1 | |
LOC105373279 | XR_007067006.1 | n.136-3490G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2T3 | ENST00000359594.3 | c.299C>T | p.Ser100Leu | missense_variant | 1/1 | NM_001005495.1 | ENSP00000352604 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000731 AC: 11AN: 150574Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250654Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135444
GnomAD4 exome AF: 0.000112 AC: 163AN: 1461108Hom.: 1 Cov.: 33 AF XY: 0.0000935 AC XY: 68AN XY: 726894
GnomAD4 genome AF: 0.0000731 AC: 11AN: 150574Hom.: 0 Cov.: 26 AF XY: 0.0000680 AC XY: 5AN XY: 73498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.299C>T (p.S100L) alteration is located in exon 1 (coding exon 1) of the OR2T3 gene. This alteration results from a C to T substitution at nucleotide position 299, causing the serine (S) at amino acid position 100 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at